HBK Sorce Advisory’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-1,617
Closed -$213K 624
2024
Q1
$213K Sell
1,617
-80
-5% -$9.99K 0.01% 539
2023
Q4
$207K Sell
1,697
-113
-6% -$12.6K 0.01% 519
2023
Q3
$203K Sell
1,810
-21
-1% -$2.67K 0.01% 512
2023
Q2
$267K Buy
1,831
+82
+5% +$11.1K 0.01% 471
2023
Q1
$226K Sell
1,749
-1,985
-53% -$249K 0.01% 504
2022
Q4
$476K Buy
3,734
+1,760
+89% +$204K 0.01% 423
2022
Q3
$206K Buy
+1,974
New +$217K 0.01% 450
2022
Q2
Sell
-2,215
Closed -$283K 570
2022
Q1
$283K Sell
2,215
-6
-0.3% -$723 0.02% 411
2021
Q4
$274K Buy
2,221
+734
+49% +$96.1K 0.01% 471
2021
Q3
$211K Sell
1,487
-87
-6% -$12.8K 0.01% 544
2021
Q2
$246K Sell
1,574
-170
-10% -$27.5K 0.01% 494
2021
Q1
$271K Buy
1,744
+193
+12% +$29.9K 0.02% 424
2020
Q4
$232K Sell
1,551
-134
-8% -$18.9K 0.01% 444
2020
Q3
$223K Buy
+1,685
New +$220K 0.02% 403

Other funds holding ZBH

HBK Sorce Advisory's ZBH Position: Q2 2024 in Review

HBK Sorce Advisory sold out of Zimmer Biomet (ZBH) in Q2 2024, closing a stake of 1,617 shares — an estimated $213K sold.

HBK Sorce Advisory first reported a position in ZBH in Q3 2020 and held it in 14 quarters. The position peaked at $476K in Q4 2022. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • HBK Sorce Advisory reported no remaining Zimmer Biomet position as of Q2 2024 after selling out during the quarter.
  • HBK Sorce Advisory sold 1,617 Zimmer Biomet shares in Q2 2024, an estimated $213K.
  • HBK Sorce Advisory first reported a position in Zimmer Biomet in Q3 2020 and held it in 14 quarters.
  • HBK Sorce Advisory's Zimmer Biomet position peaked at $476K in Q4 2022.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on HBK Sorce Advisory's 13F filing for Q2 2024, filed 8 Aug 2024.